Publications by authors named "Rongyu Zang"

Claim this Profile
S
Surgical technique of hepato-celiac lymphadenectomy in relapsed ovarian cancer.
Libing Xiang, Yulian Chen, Shuang Ye, Rong Jiang, Lina Shen, Rongyu Zang

Int J Gynecol Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival impact and prognostic factors of secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a systematic review and trial-level meta-analysis.
Ji Hyun Kim, Myong Cheol Lim, Eun Taeg Kim, Uisuk Kim, Sholanki Halder, Rongyu Zang

Int J Gynecol Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal timing of primary debulking surgery in advanced ovarian cancer: insights from the TRUST trial.
Tingyan Shi, Yulian Chen, Rong Jiang, Libing Xiang, Jihong Liu, Rongyu Zang

J Gynecol Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
gBRCA1 and gBRCA2 mutations in specific different domains affect ovarian cancer prognosis: A multicenter retrospective study.
Yingying Zhu, Yingying Wang, Zhen Shen, Lina Shen, Hanyuan Liu, Rongyu Zang

Chin Med J (Engl)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label randomized active-controlled phase II clinical study to assess the efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer (PROFECTA-II/GOG-3044).
Thomas J Herzog, John B Liao, Karen Finkelstein, Lyndsay Willmott, Wei Duan, Rong-Yu Zang

Gynecol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgery versus no surgery in platinum-sensitive relapsed ovarian cancer: final overall survival analysis of the SOC-1 randomized phase 3 trial.
Rong Jiang, Yanling Feng, Yulian Chen, Xi Cheng, Tingyan Shi, Rongyu Zang

Nat Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shanghai Gynecologic Oncology Group's consensus on the academic and industry's clinical trial types.
Tingyan Shi, Jihong Liu, Jianqing Zhu, Xipeng Wang, Wei Jiang, Rongyu Zang

Chin Med J (Engl)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Supragastric lesser sac: an insidious site for surgical exploration during the debulking surgery in advanced ovarian cancer.
Yulian Chen, Zhuozhen Sun, Songqi Cai, Yan Hu, Rong Jiang, Rongyu Zang

J Gynecol Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer.
Huayi Li, Zikun Peng, Jianqing Zhu, Weidong Zhao, Yi Huang, Rongyu Zang

BMC Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic targeting of CPSF3-dependent transcriptional termination in ovarian cancer.
Peiye Shen, Kaiyan Ye, Huaijiang Xiang, Zhenfeng Zhang, Qinyang He, Rongyu Zang

Sci Adv· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Splenectomy via the posterolateral approach in ovarian cancer.
Libing Xiang, Yulian Chen, Yixuan Liu, Zhihua Huang, Rongyu Zang

Int J Gynecol Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resection of metastatic ovarian cancer in the supragastric lesser sac in 10 steps.
Libing Xiang, Yulian Chen, Lina Shen, Zhihua Huang, Rongyu Zang

Int J Gynecol Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of a mouse model for ovarian cancer-associated venous thromboembolism.
Sining Ma, Sheng Yin, Yiyan Zheng, Rongyu Zang

Exp Biol Med (Maywood)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Nitrite Supplementation on Bioactive Peptides during Sausage Processing.
Rongyu Zang, Qunli Yu, Zonglin Guo

Foods· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Who really benefits from intraperitoneal chemotherapy for advanced ovarian cancer? A treatment-free survival analysis of the AICE trial.
Libing Xiang, Lina Shen, Yulian Chen, Yi Guo, Rong Jiang, Rongyu Zang

BJOG· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation profiles in circulating cell-free DNA predict acquired resistance to olaparib in high-grade serous ovarian carcinoma.
Dianxing Hu, Ensong Guo, Bin Yang, Xu Qin, Yu Fu, Rongyu Zang

Cancer Sci· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
Ignace Vergote, Antonio Gonzalez-Martin, Domenica Lorusso, Charlie Gourley, Mansoor Raza Mirza, Rongyu Zang

Lancet Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study.
Tingyan Shi, Libing Xiang, Jianqing Zhu, Jihong Liu, Ping Zhang, Rongyu Zang

J Gynecol Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Wip1 suppresses angiogenesis through the STAT3-VEGF signalling pathway in serous ovarian cancer.
Sheng Yin, Lina Yang, Yiyan Zheng, Rongyu Zang

J Ovarian Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olaparib Maintenance Monotherapy in Asian Patients with Platinum-Sensitive Relapsed Ovarian Cancer: Phase III Trial (L-MOCA).
Qinglei Gao, Jianqing Zhu, Weidong Zhao, Yi Huang, Ruifang An, Rongyu Zang

Clin Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MS: Wip1 suppresses angiogenesis through the STAT3-VEGF signalling pathway in serous ovarian cancer.
Sheng Yin, Lina Yang, Yiyan Zheng, Rongyu Zang

J Ovarian Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigation of the Potential Mechanisms Underlying Nuclear F-Actin Organization in Ovarian Cancer Cells by High-Throughput Screening in Combination With Deep Learning.
Wei Wu, Xiaoxia Xing, Mingyang Wang, Yinzhou Feng, Nina Wietek, Rongyu Zang

Front Cell Dev Biol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SOX17 and PAX8 constitute an actionable lineage-survival transcriptional complex in ovarian cancer.
Lifeng Lin, Kaixuan Shi, Shaoqing Zhou, Mei-Chun Cai, Caiyan Zhang, Jingyu Zang, Rongyu Zang

Oncogene· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer.
Philipp Harter, Jalid Sehouli, Ignace Vergote, Gwenael Ferron, Alexander Reuss, Rongyu Zang

N Engl J Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-Associated Fibroblast-Derived Interleukin-8 Promotes Ovarian Cancer Cell Stemness and Malignancy Through the Notch3-Mediated Signaling.
Zhaodong Ji, Wenjuan Tian, Wen Gao, Rongyu Zang, Huaying Wang

Front Cell Dev Biol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis